Administration of 11β-HSD1 inhibitor decreased fibrosis and the expression of ANP in the heart, indicating that 11β-HSD1 inhibitor rescues diabetic cardiomyopathy. The gene discussed is NPPA; the disease is diabetic cardiomyopathy.